The Comprehensive Geriatric Assessment analyzes the health and quality of life of the elderly. Basic and instrumental daily activities may be compromised due to neuroimmunoendocrine changes, and studies suggest that possible immunological changes occur during infections in the elderly. Thus, this study aimed to analyze cytokine and melatonin levels in serum and correlate the Comprehensive Geriatric Assessment in elderly patients with SARS-CoV-2 infection. The sample consisted of 73 elderly individuals, 43 of whom were without infection and 30 of whom had positive diagnoses of COVID-19. Blood samples were collected to quantify cytokines by flow cytometry and melatonin by ELISA. In addition, structured and validated questionnaires were applied to assess basic (Katz) and instrumental (Lawton and Brody) activities. There was an increase in IL-6, IL-17, and melatonin in the group of elderly individuals with infection. In addition, a positive correlation was observed between melatonin and IL-6 and IL-17 in elderly patients with SARS-CoV-2 infection. Furthermore, there was a reduction in the score of the Lawton and Brody Scale in the infected elderly. These data suggest that the melatonin hormone and inflammatory cytokines are altered in the serum of the elderly with SARS-CoV-2 infection. In addition, there is a degree of dependence, mainly regarding the performance of daily instrumental activities, in the elderly. The considerable impact on the elderly person’s ability to perform everyday tasks necessary for independent living is an extremely important result, and changes in cytokines and melatonin probably are associated with alterations in these daily activities of the elderly.
Background/Objectives: Resistin is an adipokine involved in obesity pathogenesis, but its effects on blood and colostrum immune cells from obese mothers remain unclear. This study evaluated the functional activity of phagocytes modulated by resistin in blood and colostrum from overweight and obese mothers. Methods: An observational study was conducted with 82 postpartum women divided according to pregestational BMI into control, overweight, and obese groups. Blood and colostrum samples were collected to determine resistin levels and assess the functional activity of mononuclear (MN) cells. Results: Plasma resistin levels were higher in overweight mothers, whereas colostrum levels were lower in obese mothers. Resistin treatment enhanced superoxide release in both colostrum and blood phagocytes, independent of maternal weight status. In the presence of enteropathogenic Escherichia coli (EPEC), resistin-treated phagocytes from both colostrum and maternal blood showed increased superoxide production. In blood cells from overweight mothers, resistin reduced superoxide dismutase (SOD) concentration, while in colostrum, the highest SOD levels were observed in cultures of resistin-treated cells from mothers with altered weight, regardless of weight status. Blood and colostrum cells treated with resistin increased phagocytosis rates. In colostrum, resistin-treated cells from eutrophic mothers showed high microbicidal indices, whereas cells from mothers with altered weight showed reduced microbicidal indices. In colostrum cells, adipokine levels were reduced in the obesity group. Conclusions: Resistin modulates oxidative metabolism and the functional activity of blood and colostrum phagocytes across all maternal weight statuses, suggesting a possible role for resistin in the maternal immune response associated with obesity.
Background: Type 2 diabetes mellitus is characterized by chronic low-grade inflammation, immune dysregulation, and metabolic impairment. This study investigated cytokine profiles associated with physical exercise and insulin therapy in patients with Type 2 diabetes mellitus. Methods: Blood samples were collected from 51 volunteers to evaluate metabolic parameters and cytokine concentrations. According to glycemic status and insulin use, participants were classified into non-diabetic, non-insulin-dependent Type 2 Diabetes Mellitus, and insulin-dependent Type 2 Diabetes Mellitus groups. Results: Physically active individuals with non-insulin-dependent Type 2 Diabetes Mellitus exhibited increased IL-4, IL-6, and IL-10 levels, suggesting enhanced immunoregulatory and anti-inflammatory responses. Physically active patients with insulin-dependent Type 2 Diabetes Mellitus showed elevated IL-17 concentrations. In contrast, sedentary individuals with insulin-dependent Type 2 Diabetes Mellitus exhibited higher TNF-α levels, indicating a more pronounced proinflammatory profile. IFN-γ concentrations were significantly higher in patients with insulin-dependent Type 2 Diabetes Mellitus, regardless of exercise status. Correlation analyses demonstrated distinct cytokinemetabolic interaction patterns according to metabolic condition and physical exercise. Conclusion: Cytokines can serve as molecular markers of immunometabolic responses associated with physical exercise and insulin therapy in Type 2 Diabetes Mellitus, reflecting alterations in systemic inflammatory regulation and immune–metabolic crosstalk related to glycemic adaptation.
Background: Gestational diabetes mellitus (GDM) is one of the most common metabolic disorders during pregnancy and is associated with pregnancy-specific urinary incontinence (PSUI) and long-term pelvic floor dysfunction. Hyperglycemia-induced inflammation, oxidative stress, and diabetic myopathy may impair pelvic floor adaptation, increasing the risk of pelvic floor muscle injury (PFMI) and pelvic organ prolapse (POP). Physical activity is a key non-pharmacological strategy to attenuate diabetic myopathy and promote pelvic floor adaptation. Serotonin has emerged as a potential mediator linking metabolic dysregulation, neuroimmunoendocrine signaling, and pelvic floor adaptation because of its neurological, metabolic, immunomodulatory, and tissue-homeostatic functions. Thus, this narrative review synthesizes and integrates current evidence on the relationships among GDM, diabetic myopathy, pelvic floor dysfunction, serotonin signaling, and physical activity. Methods: We examined the available literature to identify potential mechanistic interactions, current knowledge gaps, and emerging therapeutic perspectives. Results: Current evidence indicates that GDM-induced metabolic and inflammatory alterations may contribute to impaired pelvic floor adaptation and increase the risk of PSUI and POP. Although physical activity and serotonin independently influence metabolic regulation and pelvic floor function, their interaction remains poorly understood. Unlike previous reviews that address these mechanisms separately, we propose a conceptual model connecting metabolic, neuromuscular, and immunological pathways to explain pelvic floor dysfunction in women with GDM. Conclusions: This integrative framework can support the development of targeted preventive and therapeutic strategies while guiding future mechanistic and clinical research.